Venture Fund VII Lp Arch serves as Executive at AGIOS PHARMACEUTICALS INC, where they oversee executive responsibilities. Since joining the company, Venture Fund VII Lp Arch has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Feb 19, 2015 involved transacting 386,074 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Feb 19, 2015 | AGIO | $0 | Other | 386,074 | $N/A | Discretionary |
Venture Fund VII Lp Arch currently holds 3,088,590 shares of AGIOS PHARMACEUTICALS INC (AGIO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Venture Fund VII Lp Arch has been a net neutral trader of AGIO stock. They have purchased $0 and sold $0 worth of shares.
Venture Fund VII Lp Arch's most recent insider trade was on Feb 19, 2015, when they sold 386,074 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted